Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.
暂无分享,去创建一个
A. Shapiro | M. L. Hubbard | J. Mandeli | G Fulop | E Shapiro | A K Shapiro | M Hubbard | J Mandeli | J Nordlie | R A Phillips | R. Phillips | G. Fulop | J. Nordlie | E. Shapiro | J. Mandeli | M. Hubbard
[1] J. Davis,et al. New pharmacological approaches in the treatment of Tourette syndrome. , 1982, Advances in neurology.
[2] Testing Hypotheses in the Two‐period Change‐over with Binary Data , 1978 .
[3] B. Pakkenberg,et al. Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[4] H. Takemoto,et al. The effect of penfluridol and some psychotropic drugs on monoamine metabolism in central nervous system. , 1975, European journal of pharmacology.
[5] J. Gart. An exact test for comparing matched proportions in crossover designs , 1969 .
[6] J. Grizzle. THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.
[7] M. Segawa,et al. Tourette syndrome in oriental children: clinical and pathophysiological considerations. , 1982, Advances in neurology.
[8] A. Shapiro,et al. Treatment of Tourette disorder with penfluridol. , 1983, Comprehensive Psychiatry.
[9] M. Baron,et al. Genetic analysis of Tourette syndrome suggesting major gene effect. , 1981, American journal of human genetics.
[10] J. A. Gomes,et al. ECG changes during haloperidol and pimozide treatment of Tourette's disorder. , 1987, The American journal of psychiatry.
[11] U. Ungerstedt,et al. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.
[12] A. Shapiro,et al. Treatment of Gilles de la Tourette syndrome with pimozide. , 1983, The American journal of psychiatry.
[13] G. Chouinard,et al. Phenothiazine-induced ECG abnormalities: effect of a glucose load. , 1977, Archives of general psychiatry.
[14] S. Matthysse. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? , 1973, Federation proceedings.
[15] C. V. Ford,et al. An objective evaluation of haloperidol in Gilles de la Tourette's syndrome. , 1969, Diseases of the nervous system.
[16] H. Moldofsky,et al. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. , 1978, The American journal of psychiatry.
[17] F. Abuzzahab,et al. Gilles de la Tourette syndrome , 1978, Neurology.
[18] S. Enna,et al. Overview of pharmacological approaches to therapy for Tourette syndrome. , 1982, Advances in neurology.
[19] A. Shapiro,et al. Pimozide treatment of tic and Tourette disorders. , 1987, Pediatrics.
[20] B. Shaywitz,et al. Clonidine ameliorates Gilles de la Tourette syndrome. , 1980, Archives of general psychiatry.
[21] A. Moss,et al. Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. , 1982, Modern concepts of cardiovascular disease.
[22] P. Seeman,et al. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.
[23] M. Segawa,et al. Gilles de la tourette syndrome in oriental children , 1979, Brain and Development.
[24] A. Shapiro,et al. Treatment of Tourette's syndrome with haloperidol, review of 34 cases. , 1973, Archives of general psychiatry.
[25] L. Beani,et al. Effect of haloperidol and pimozide on acetylcholine output from the cerebral cortex in rats and guinea pigs. , 1980, European journal of pharmacology.
[26] B. Shaywitz,et al. Clonidine in the treatment of Tourette syndrome: a review of data. , 1982, Advances in neurology.
[27] A. Shapiro,et al. Controlled study of pimozide vs. placebo in Tourette's syndrome. , 1984, Journal of the American Academy of Child Psychiatry.
[28] G. Sedvall,et al. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain , 1970, The Journal of pharmacy and pharmacology.
[29] S. Snyder,et al. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. , 1983, Proceedings of the National Academy of Sciences of the United States of America.